Please login to the form below

Not currently logged in
Email:
Password:

binge eating disorder

This page shows the latest binge eating disorder news and features for those working in and with pharma, biotech and healthcare.

Shire pitching at adult ADHD product launch in 2017

Shire pitching at adult ADHD product launch in 2017

The FDA has agreed a regulatory route for Shire's attention deficit hyperactivity disorder (ADHD) product for adults, potentially opening up a lucrative new market for the company's franchis e. ... Breaking into the adult ADHD - as well as a sideways

Latest news

  • Monica Seles to front Shire’s binge eating disorder campaign Monica Seles to front Shire’s binge eating disorder campaign

    Seles recently admitted to experiencing binge eating disorder when she was a professional tennis player in the 1990s. ... There is a misconception that adults with binge eating disorder fit a certain profile,” said Seles.

  • Shire gets FDA nod for first binge-eating treatment Shire gets FDA nod for first binge-eating treatment

    Vyvanse already available as ADHD treatment. Shire's big-selling Vyvanse brand has become the first drug approved in the US to help people with binge-eating disorder. ... Binge eating disorder is not just about eating a lot; it is that, plus being out of

  • Shire to file Vyvanse for binge-eating in Q3 Shire to file Vyvanse for binge-eating in Q3

    Shire is planning a marketing application in binge-eating in the third quarter, which, if approved, would be the first FDA-backed drug for the condition, potentially adding tens of millions ... Shire wants to achieve with binge-eating disorder what it

  • Shire's ADHD drug fails in depression trial Shire's ADHD drug fails in depression trial

    Company drops Vyvanse for use in major depressive disorder. Shire's hopes to expand the uses of its big-selling behavioural medicine Vyvanse were dashed after the drug disappointed in a ... of adults with binge eating disorder.

  • Shire weathers generic Adderall XR challenge Shire weathers generic Adderall XR challenge

    attention deficit-hyperactivity disorder (ADHD) drug Adderall XR (amphetamine and dextroamphetamine). ... Russell highlighted developments, such as potential new indications for Vyvanse, including major depressive disorder, binge eating disorder and

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics